CVRdatabase
Menu

Zpd A/S

Public limited companyCVR 32834825EsbjergActive

Zpd A/S is a public limited company, based in Esbjerg, active in manufacture of basic pharmaceutical products, founded in 2010. Net profit fell 21% from 2024 to 2025, ending at DKK 10.2m. Measured by gross profit, it ranks no. 4 of 14 companies in the industry in the database.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 52.7m+6.9% vs. 2024
Net profitDKK 10.2m−20.6% vs. 2024
EquityDKK 217.6m+4.2% vs. 2024
Employees54latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 7% (2024 → 2025), to DKK 52.7m.
  • Net profit fell 21% (2024 → 2025), to DKK 10.2m.
  • Equity rose 4% (2024 → 2025), to DKK 217.6m.

Employees

  • 8 more employees than a year earlier: 54 (08/2026) against 46 (08/2025).

Management and owners, last 24 months

  • New in management: Ken Motegi (board member, 01/01/2026).
  • Stepped down: Mitsuru Iwai (board member, 01/01/2026).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 50mDKK 100mDKK 150mDKK 200m202020212022202320242025
EquityNet profit
Financial figures for Zpd A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit35,56835,20037,25643,78849,31552,704+6.9%
Operating profit (EBIT)8,6729,8199,64112,92513,26010,657−19.6%
Profit before tax7,5948,8398,97615,11016,43412,935−21.3%
Net profit5,9546,9637,06711,82412,86410,220−20.6%
Total assets182,960189,620197,014209,257221,038236,052+6.8%
Equity171,203178,166185,232197,056208,920217,641+4.2%
Liabilities8,6478,3108,2637,4487,43912,049+62%
Cash and cash equivalents98,10182,422101,848103,054129,751102,904−20.7%
Average number of employees353535394248+14.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50m202020212022202320242025
Gross profitMedian, the industry (14 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Zpd A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202527/03/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202425/03/2025The companyPDFXBRL
202301/01/2023 – 31/12/202303/04/2024The companyPDFXBRL
202201/01/2022 – 31/12/202230/03/2023The companyPDFXBRL
202101/01/2021 – 31/12/202130/05/2022The companyPDFXBRL
202001/01/2020 – 31/12/202010/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0102030405009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

14 companies in the database

Comparison with the other companies in manufacture of basic pharmaceutical products based on the latest financial year.

Gross profitDKK 52.7mNo. 4 of 14
Better than 77% of the companies in the industry
EquityDKK 217.6mNo. 3 of 14
Better than 85% of the companies in the industry
Number of employees54No. 5 of 14
Better than 69% of the companies in the industry

Industry median: gross profit DKK 13.9m, net profit DKK 80,789, equity DKK 10.1m, 19 employees.

DKK 100kDKK 749kDKK 5.6mDKK 42mDKK 161mHere
Distribution of gross profit for 14 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 1,679of 4,412
Better than 62%
No. 323of 4,466
Better than 93%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 1,352of 24,791
Better than 95%
No. 729of 24,909
Better than 97%
All companies of type A/S18,025 companies in the comparison
No. 2,774of 17,786
Better than 84%
No. 1,354of 18,024
Better than 92%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Manufacture of basic pharmaceutical products
Gross profit
  1. Zpd A/SDKK 52.7m
  2. Xellia Pharmaceuticals ApSDKK 314.9m
  3. Glycom Manufacturing A/SDKK 226.3m
Net profit
  1. Zpd A/SDKK 10.2m
  2. Xellia Pharmaceuticals ApSDKK 213.7m
  3. Glycom Manufacturing A/SDKK 69.2m
Equity
  1. Zpd A/SDKK 217.6m
  2. Xellia Pharmaceuticals ApSDKK 404.6m
  3. Glycom Manufacturing A/SDKK 577.7m
Employees
  1. Zpd A/S54
  2. Xellia Pharmaceuticals ApS458
  3. Glycom Manufacturing A/S116

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Zeria Pharmaceutical Co. Ltd.100%
Zpd A/S

Management

5 active registrations

Executive management

Executive management at Zpd A/S
NameRoleAppointed
Frank MarekCEO01/01/2017
Hiroyuki ShinyaDirector01/01/2022

Board of directors

Board of directors at Zpd A/S
NameRoleAppointed
Frank MarekBoard member01/01/2017
Masakazu SakuraiChair of the board01/04/2023
Ken MotegiBoard member01/01/2026
Former management (26)
Former management at Zpd A/S
NameRoleAppointedResigned
Svend BlankholmBoard member04/03/201016/09/2010
Niels Ulrik HeineBoard member04/03/201016/09/2010
Peter RørvigBoard member04/03/201022/08/2012
Peter RørvigDirector04/03/201016/09/2010
Helle RørvigBoard member04/03/201016/09/2010
Robert Villum NielsenDirector16/09/201031/03/2016
Mitsuhiro TagoBoard member16/09/201018/04/2011
Shigeya FuruhataChair of the board16/09/201024/03/2014
Elio Ramon LooBoard member16/09/201024/03/2014
Elio Ramon LooCEO16/09/201024/03/2014
Helle RørvigDirector05/11/201022/08/2012
Nobuhito HashimotoBoard member18/04/201128/06/2012
Akihisa OnoBoard member28/06/201211/05/2015
Hiroyasu NishiokaBoard member09/07/201301/01/2017
Keiji IshiyamaBoard member09/07/201301/01/2017
Frank MarekChief financial officer01/09/201331/12/2016
Hiroyasu NishiokaCEO24/03/201401/01/2017
Makoto KishimotoChair of the board24/03/201428/05/2018
Junkichi IzumiBoard member11/05/201501/01/2017
Ryu NakaoDirector01/08/201631/12/2021
Katsuyuki IshiiBoard member01/01/201710/07/2020
Hiroki KatoChair of the board28/05/201808/02/2019
Yoshihiro HiragaChair of the board08/02/201922/04/2021
Mitsuru IwaiBoard member10/07/202001/01/2026
Ken MotegiChair of the board22/04/202112/07/2021
Kenichi SuzukiChair of the board12/07/202101/04/2023

Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.

Address and production units

1 active production units

H E Bluhmes Vej 63
6700 Esbjerg

Esbjerg Municipality · Postcode 6700

Production units
Production unitAddressEmployeesP number
ZPD A/SH E Bluhmes Vej 63, 6700 Esbjerg541015956476

Purpose

Selskabets formål er at drive fabrikation og handel med kemiske produkter.

The purpose is quoted from the register in Danish.

Changes year by year

70 registered events
20263 changesaccounts 1 · management 2
  • Annual report for 2025 published
  • Ken Motegi appointed board member
  • Mitsuru Iwai stepped down as board member
20251 changeaccounts 1
  • Annual report for 2024 published
20241 changeaccounts 1
  • Annual report for 2023 published
20233 changesmanagement 2 · accounts 1
  • Masakazu Sakurai appointed chair of the board
  • Kenichi Suzuki stepped down as chair of the board
  • Annual report for 2022 published
20222 changesaccounts 1 · management 1
  • Annual report for 2021 published
  • Hiroyuki Shinya appointed director
20216 changesmanagement 5 · accounts 1
  • Ryu Nakao stepped down as director
  • Kenichi Suzuki appointed chair of the board
  • Ken Motegi stepped down as chair of the board
  • Annual report for 2020 published
  • Ken Motegi appointed chair of the board
  • Yoshihiro Hiraga stepped down as chair of the board
20202 changesmanagement 2
  • Mitsuru Iwai appointed board member
  • Katsuyuki Ishii stepped down as board member
20192 changesmanagement 2
  • Yoshihiro Hiraga appointed chair of the board
  • Hiroki Kato stepped down as chair of the board
20182 changesmanagement 2
  • Hiroki Kato appointed chair of the board
  • Makoto Kishimoto stepped down as chair of the board
20177 changesmanagement 7
  • Frank Marek appointed board member
  • Frank Marek appointed ceo
  • Katsuyuki Ishii appointed board member
  • Junkichi Izumi stepped down as board member
  • Hiroyasu Nishioka stepped down as ceo
  • Keiji Ishiyama stepped down as board member
  • Hiroyasu Nishioka stepped down as board member
20163 changesmanagement 3
  • Frank Marek stepped down as chief financial officer
  • Ryu Nakao appointed director
  • Robert Villum Nielsen stepped down as director
20152 changesmanagement 2
  • Junkichi Izumi appointed board member
  • Akihisa Ono stepped down as board member
20145 changesmanagement 5
  • Makoto Kishimoto appointed chair of the board
  • Hiroyasu Nishioka appointed ceo
  • Elio Ramon Loo stepped down as ceo
  • Elio Ramon Loo stepped down as board member
  • Shigeya Furuhata stepped down as chair of the board
20135 changesmanagement 3 · ownership 1 · name 1
  • Frank Marek appointed chief financial officer
  • Zeria Pharmaceutical Co. Ltd. registered as owner (100%)
  • Keiji Ishiyama appointed board member
  • Hiroyasu Nishioka appointed board member
  • Name changed from BIOFAC ESBJERG A/S to ZPD A/S
20125 changesmanagement 4 · address 1
  • Helle Rørvig stepped down as director
  • Peter Rørvig stepped down as board member
  • Moved to H E Bluhmes Vej 63, 6700 Esbjerg
  • Akihisa Ono appointed board member
  • Nobuhito Hashimoto stepped down as board member
20112 changesmanagement 2
  • Nobuhito Hashimoto appointed board member
  • Mitsuhiro Tago stepped down as board member
201019 changesmanagement 15 · industry 1 · address 2 · founded 1
  • Helle Rørvig appointed director
  • Industry changed to Manufacture of basic pharmaceutical products (211000)
  • Moved to Englandsvej 350, 2770 Kastrup
  • Moved to H E Bluhmes Vej 63, 6700 Esbjerg
  • Mitsuhiro Tago appointed board member
  • Elio Ramon Loo appointed ceo
  • Elio Ramon Loo appointed board member
  • Shigeya Furuhata appointed chair of the board
  • Robert Villum Nielsen appointed director
  • Niels Ulrik Heine stepped down as board member
  • Helle Rørvig stepped down as board member
  • Peter Rørvig stepped down as director
  • Svend Blankholm stepped down as board member
  • Registered as BIOFAC ESBJERG A/S
  • Niels Ulrik Heine appointed board member
  • Helle Rørvig appointed board member
  • Peter Rørvig appointed director
  • Peter Rørvig appointed board member
  • Svend Blankholm appointed board member

Related companies

Same industry in Esbjerg

See all →

Same people in management

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction